CHARACTERIZATION OF MELPHALAN-GLUTATHIONE ADDUCTS WHOSE FORMATION IS CATALYZED BY GLUTATHIONE TRANSFERASES

被引：182

作者：

DULIK, DM ^{[1
]}

FENSELAU, C ^{[1
]}

HILTON, J ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 19期

关键词：

D O I：

10.1016/0006-2952(86)90444-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：3405 / 3409

页数：5

相关论文

共 13 条

[1] EVANS TL, 1982, CANCER CHEMOTH PHARM, V8, P175
[2] FAIRLAMB AH, 1985, SCIENCE, V227, P1495
[3] FENSELAU C, 1978, PHYSICAL METHODS MOD, V1, P123
[4] FURNER RL, 1976, DRUG METAB DISPOS, V4, P577
[5] GOLDENBERG GJ, 1984, HDB EXPT PHARM ANTIT, P198
[6] Habig WH, 1974, J BIOL CHEM, V249, P7120
[7] AUGMENTATION OF ADRIAMYCIN, MELPHALAN, AND CISPLATIN CYTO-TOXICITY IN DRUG-RESISTANT AND DRUG-SENSITIVE HUMAN OVARIAN-CARCINOMA CELL-LINES BY BUTHIONINE SULFOXIMINE MEDIATED GLUTATHIONE DEPLETION
HAMILTON, TC
WINKER, MA
LOUIE, KG
BATIST, G
BEHRENS, BC
TSURUO, T
GROTZINGER, KR
MCKOY, WM
YOUNG, RC
OZOLS, RF
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) : 2583 - 2586
[8] LEHMAN JP, 1981, DRUG METAB DISPOS, V9, P15
[9] PALLANTE SL, 1986, DRUG METAB DISPOS, V14, P313
[10] POHL LR, 1981, DRUG METAB DISPOS, V9, P334